ClinConnect ClinConnect Logo
Search / Trial NCT06960642

Dosage of Early Rehabilitation of ICU Patients

Launched by MEDICAL UNIVERSITY OF VIENNA · May 5, 2025

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Early Ambulation Early Rehabilitation Early Mobilisation Physiotherapy Physical Therapy Icuaw Pics Intensive Care Unit Acquired Weakness Post Intensive Care Syndrom Physical Function Critical Care Interprofessional Nursing

ClinConnect Summary

This clinical trial, titled "Dosage of Early Rehabilitation of ICU Patients," is studying how different ways of getting patients moving in the Intensive Care Unit (ICU) can help them recover better. The researchers want to understand which methods of mobilization—like physical therapy and early walking—lead to the best outcomes for patients in terms of their physical abilities and overall quality of life. They plan to gather information from over 6,000 patients from various countries to learn about these practices worldwide.

To be eligible for this study, participants must be adults aged 18 or older who are admitted to the ICU and are expected to stay there for more than 24 hours. Patients who are receiving end-of-life care, those whose treatment plans are not finalized, individuals who may not be able to participate fully due to their health status, or those with language barriers will not be included. Participants in this study won’t receive any new treatments; instead, researchers will collect standard information about their care and recovery. This trial aims to improve future rehabilitation practices for ICU patients by learning from current practices.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (≥ 18 years old) within 48 hours of ICU admission
  • Expected to stay \> 24 hours in the ICU
  • Exclusion Criteria:
  • Patients who receive end-of-life care at the time of screening
  • Patients whose treatment plans are still under discussion and/or not all team members are committed to full active treatment
  • Patients whose functional status is unlikely to be obtainable
  • Patients with language barriers

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Patients applied

0 patients applied

Trial Officials

Stefan J Schaller, MD

Principal Investigator

Medical University of Vienna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported